Search research articles
Contact Us
Filters
Showing results (531-540 of 599) with videos related to
Page
of 60
Sort By:
Journal of Medicinal Chemistry
|
April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) Substitution
Dilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
ACS Omega
|
November 10, 2018
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Dilip K Tosh, Antonella Ciancetta, Philip Mannes, et al.
Trends in Pharmacological Sciences
|
January 5, 2005
The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor
Maria P Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, et al.
Journal of Computer-Aided Molecular Design
|
July 22, 2015
Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information
Silvia Paoletta, Davide Sabbadin, Ivar von Kügelgen, et al.
Nucleosides & Nucleotides
|
April 5, 2016
A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS
Suhaib M Siddiqi, Xiao-Duo Ji, Neli Melman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2023
Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition
Jung-Eun Park, Klara Kirsch, Hobin Lee, et al.
Arthritis Research & Therapy
|
December 10, 2022
Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models
Ane Larrañaga-Vera, Kiran S Toti, James S Flatow, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor
Lak Shin Jeong, Hyuk Woo Lee, Hea Ok Kim, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Chimeras Derived from a P2Y<sub>14</sub> Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation
Bin Xu, Andrew Stephens, Gary Kirschenheuter, et al.
Page
of 60
Search research articles
Search
Showing results (531-540 of 599) with videos related to
Sort By:
Page
of 60
Journal of Medicinal Chemistry
|
April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) Substitution
Dilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
ACS Omega
|
November 10, 2018
Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Dilip K Tosh, Antonella Ciancetta, Philip Mannes, et al.
Trends in Pharmacological Sciences
|
January 5, 2005
The recently deorphanized GPR80 (GPR99) proposed to be the P2Y15 receptor is not a genuine P2Y receptor
Maria P Abbracchio, Geoffrey Burnstock, Jean-Marie Boeynaems, et al.
Journal of Computer-Aided Molecular Design
|
July 22, 2015
Modeling ligand recognition at the P2Y12 receptor in light of X-ray structural information
Silvia Paoletta, Davide Sabbadin, Ivar von Kügelgen, et al.
Nucleosides & Nucleotides
|
April 5, 2016
A SURVEY OF NONXANTHINE DERIVATIVES AS ADENOSINE RECEPTOR LIGANDS
Suhaib M Siddiqi, Xiao-Duo Ji, Neli Melman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 21, 2023
Specific inhibition of an anticancer target, polo-like kinase 1, by allosterically dismantling its mechanism of substrate recognition
Jung-Eun Park, Klara Kirsch, Hobin Lee, et al.
Arthritis Research & Therapy
|
December 10, 2022
Novel alendronate-CGS21680 conjugate reduces bone resorption and induces new bone formation in post-menopausal osteoporosis and inflammatory osteolysis mouse models
Ane Larrañaga-Vera, Kiran S Toti, James S Flatow, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 11, 2007
Design, synthesis, and anti-tumor activity of 4'-thionucleosides as potent and selective agonists at the human A3 adenosine receptor
Lak Shin Jeong, Hyuk Woo Lee, Hea Ok Kim, et al.
ACS Pharmacology & Translational Science
|
October 18, 2024
Chimeras Derived from a P2Y<sub>14</sub> Receptor Antagonist and UDP-Sugar Agonists for Potential Treatment of Inflammation
Zhiwei Wen, Asmita Pramanik, Sarah A Lewicki, et al.
Journal of Medicinal Chemistry
|
December 13, 2002
Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation
Bin Xu, Andrew Stephens, Gary Kirschenheuter, et al.
Page
of 60